Priyanka Rani | Pharmaceuticas | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Priyanka Rani
Researcher Priyanka Rani
Affiliation DAV University Jalandhar
Country India
Scopus ID 57197006966
Documents 5
Citations 185
h-index 4
Subject Area Pharmaceuticas
Event International Young Scientists Award
ORCID 0009-0005-3333-8264

Priyanka Rani
DAV University Jalandhar, India

Priyanka Rani, affiliated with DAV University Jalandhar, has established an active research profile within the pharmaceutical sciences through scholarly publications, citation impact, and participation in academic research. Her documented work reflects sustained engagement in pharmaceutical investigations and contributes to the broader scientific literature. With indexed publications, measurable citation performance, and an internationally identifiable research profile through Scopus, ORCID, and Google Scholar, her academic achievements align with the evaluation principles commonly associated with international research awards.[1]

Abstract

Priyanka Rani has contributed to pharmaceutical science through peer-reviewed research indexed in international databases. Her scholarly output demonstrates an interest in scientific investigation, publication ethics, and knowledge dissemination. With five Scopus-indexed documents, 185 citations, and an h-index of four, her profile reflects measurable research influence. These indicators, together with professional affiliations and persistent researcher identifiers, support recognition within competitive academic award programs.[1]

Keywords

  • Young Scientist Award
  • Pharmaceutical Sciences
  • Scientific Research
  • Scopus Publications
  • Citation Impact

Introduction

Scientific recognition programs encourage innovation, promote research excellence, and acknowledge individuals who contribute to the advancement of knowledge. The International Young Scientists Award emphasizes objective evaluation through publication quality, citation performance, research relevance, and academic engagement. Researchers with verified scholarly records are considered based on transparent academic indicators and documented scientific achievements.[2]

Research Profile

Priyanka Rani is associated with DAV University Jalandhar and has developed a research profile centered on pharmaceutical sciences. Her publications are indexed in Scopus and supported through internationally recognized researcher identifiers including ORCID and Google Scholar. These resources improve research visibility, facilitate citation tracking, and enable global accessibility to scholarly contributions.[1]

Research Contributions

  • Published peer-reviewed pharmaceutical research.
  • Contributed to evidence-based scientific literature.
  • Maintains internationally indexed researcher profiles.
  • Supports knowledge dissemination through scholarly publications.

Publications

The researcher has published five Scopus-indexed documents that collectively received 185 citations. These publications demonstrate continuing engagement with pharmaceutical research and contribute to scientific communication within the discipline. Citation performance indicates that the published work has attracted attention from the research community.[1]

Research Impact

Research impact is commonly evaluated through publication quality, citation metrics, research visibility, and sustained academic activity. The available bibliometric indicators associated with Priyanka Rani demonstrate measurable scholarly influence appropriate for consideration in early-career scientific recognition programs.[2]

Award Suitability

Based on publicly available academic indicators, Priyanka Rani demonstrates characteristics generally evaluated for the International Young Scientists Award, including indexed publications, citation performance, verified research profiles, and ongoing scholarly activity. These achievements provide objective evidence supporting consideration within competitive academic recognition programs while remaining subject to the official evaluation criteria established by the award organizers.[3]

Conclusion

Priyanka Rani’s documented research profile reflects sustained academic participation in pharmaceutical sciences. Her indexed publications, citation record, institutional affiliation, and internationally recognized researcher identifiers contribute to an established scholarly presence. Collectively, these measurable achievements support professional visibility and provide a sound basis for consideration in international academic recognition initiatives such as the Young Scientist Award.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Priyanka Rani, Author ID 57197006966.
    https://www.scopus.com/authid/detail.uri?authorId=57197006966
  2. ORCID. (n.d.). ORCID Research Profile.
    https://orcid.org/0009-0005-3333-8264
  3. DOI Foundation. Digital Object Identifier Reference.
    https://doi.org/10.1016/j.jep.2018.03.016

Pooja Kumari | Pharmaceutical Chemistry | Women Researcher Award

Published on by Young Scientists Awards

Ms. Pooja Kumari | Pharmaceutical Chemistry
| Women Researcher Award

JSS college of pharmacy, mysore | India

Ms. Pooja Kumari is an accomplished pharmaceutical researcher with over four years of experience in drug design, synthetic and medicinal chemistry, and scientific writing. She has expertise in computational approaches, including molecular docking, molecular dynamics simulation, QSAR, and homology modeling, alongside hands-on laboratory synthesis of novel compounds. Her Ph.D. research at JSS University focuses on designing and synthesizing novel purine derivatives as Aurora kinase-A inhibitors for breast cancer, integrating in-silico modeling with biochemical evaluation. She has contributed to medicinal chemistry through publications on pyrimidine, pyrazole, benzimidazole, and benzoxazole scaffolds, as well as reviews on pharmacogenomics and oncogenic signaling pathways, with 3 documents, 7 citations, and an h-index of 1. Pooja also has four years of teaching experience and practical guidance experience as a Research Assistant at SriramChem Laboratories. A registered pharmacist in India, she has completed workshops and certifications in AI-driven drug discovery and journal reviewing. Fluent in English and Hindi, she is currently enhancing her Dutch proficiency, reflecting adaptability and commitment to cross-cultural engagement. Her multidisciplinary expertise and strong analytical and communication skills enable her to contribute effectively in academic, research, and regulated pharmaceutical environments.

Profile: Orcid | Scopus 

Featured Publication

Kumari, P. (2026). Exploring pyrimidine scaffolds for cancer therapy: A triad of synthetic chemistry, computational studies, and in-vitro biological testing. Journal of Molecular Structure.

 

 

Blaise Dondji | Drug discovery | Best Researcher Award

Published on by Young Scientists Awards

Prof. Blaise Dondji | Drug discovery | Best Researcher Award

Distinguished Professor , Central Washington University , United States

Dr. Blaise Dondji is a Distinguished Professor in the Department of Biological Sciences at Central Washington University (CWU), USA. He specializes in immunology, infectious diseases, and parasitology, with extensive experience in teaching, mentoring, and research. Holding a Ph.D. in Parasitology from the University of Jos, Nigeria, and postdoctoral training at Yale School of Medicine and Hebrew University, Dr. Dondji has made significant contributions to parasitic disease research and immunology. His work focuses on vector-borne diseases, vaccine development, and host-pathogen interactions. He has received prestigious grants from NIH, Volkswagen Foundation, and Keck Foundation. Recognized for his teaching excellence, he has been awarded multiple faculty mentorship and excellence awards at CWU. Dr. Dondji is also actively involved in academic service, grant writing, and diversity initiatives. His dedication to research and student success continues to shape the next generation of scientists.

Profile

Scopus

🎓 Education 

Dr. Blaise Dondji holds a diverse and extensive academic background in biological sciences, specializing in parasitology and immunology. He earned his Ph.D. in Parasitology from the University of Jos, Nigeria, in 1999, following an M.Sc. in Entomology & Parasitology from the same institution in 1993. Before that, he completed both an M.Phil. (1991) and an M.Sc. (1990) in Animal Biology & Physiology at the University of Yaoundé, Cameroon, where he also obtained his B.Sc. in Zoology in 1989. His postdoctoral training includes Molecular Parasitology at the Hebrew University in Jerusalem, Israel (2002) and Immunology & Infectious Diseases at the Yale School of Medicine, USA (2007). His academic journey has been enriched by multiple prestigious fellowships, including those from UNESCO and the Brazilian Council for Scientific and Technological Advancement, equipping him with a strong foundation in parasitology, immunology, and global health research.

🏢 Experience 

Dr. Dondji is a Distinguished Professor at Central Washington University, where he has been a faculty member since 2008. He has served as Professor, Associate Professor, and Assistant Professor in the Department of Biological Sciences, mentoring undergraduate and graduate students. Additionally, he has held roles as Director of the Keck-Murdock Flow Cytometry Facility and a pre-medical and pre-dental advisor. Prior to CWU, he was a faculty member at Yale School of Medicine, supervising research in infectious diseases. His earlier career includes serving as a Senior Lecturer at the University of Ngaoundéré, Cameroon, and as a Visiting Lecturer at institutions such as Quinnipiac University and the Université Paris-Sorbonne. With decades of teaching experience in immunology, molecular biology, and parasitology, Dr. Dondji has contributed significantly to the academic and research community, shaping the next generation of scientists through his expertise and mentorship.

🏆 Awards & Honors 

Dr. Dondji has been widely recognized for his excellence in teaching, mentoring, and research. He received the 2022 Distinguished Faculty – Teaching Award at CWU, adding to previous accolades such as the 2019 Career Influencer Award and the 2018 Faculty Mentor of the Year Award. His contributions to student success have earned him multiple recognitions, including the 2013 Most Inspirational Faculty Award and the 2016 Professors’ Excellence Award from the National Residence Hall Honorary. His impact on the scientific community is also reflected in prestigious research fellowships from the Volkswagen Foundation, UNESCO, and the Brazilian Council for Scientific and Technological Advancement. He has also received major research grants, including an NIH R15 grant and funding from the Keck Foundation and Murdock Charitable Trust, highlighting his leadership in research and education.

🔬 Research Focus 

Dr. Dondji’s research focuses on immunology, parasitology, and infectious diseases, with an emphasis on host-pathogen interactions and vaccine development. His studies explore novel immunological approaches to combat parasitic infections, particularly those caused by helminths and protozoa. He has contributed significantly to understanding immune responses to parasitic diseases, investigating mechanisms of host resistance and susceptibility. His research also extends to vector-borne diseases, particularly mosquito biology and control strategies to curb malaria and other mosquito-transmitted infections. Through his work, he has secured major funding, including NIH grants, and has established state-of-the-art immunological research methodologies. Additionally, he has been actively involved in promoting public health awareness and vaccine research, furthering global efforts to mitigate the burden of infectious diseases in sub-Saharan Africa and beyond.

🔹 Conclusion

Given his exceptional research output, global impact, and dedication to scientific advancements, Dr. Blaise Dondji is a highly suitable candidate for the Best Researcher Award. His pioneering research, influential mentorship, and ability to secure significant funding position him as a distinguished scientist whose contributions have greatly advanced the field of immunology and infectious disease research.

Publication

Publication: “Distribution and ecological aspects of sand fly species from Kousseri, an endemic focus of visceral leishmaniasis in Northern Cameroon”

Authors: Tebo-Nzesseu Thierry Rostand, Tateng Ngouateu Aime, Ngouateu Omer Bébé Kenfack, Vincent Khan Payne, Blaise Dondji

Journal: Frontiers in Tropical Diseases

Year: 2024

Citations: 0

Publication: “Ecological site distribution of sand fly species of Mokolo, an endemic focus of cutaneous leishmaniasis in northern Cameroon”

Authors: Aime Tateng Ngouateu, Omer Bébé Ngouateu Kenfack, Vincent Khan Payne, Andreas Krüger, Blaise Dondji

Journal: Acta Tropica

Year: 2023

Citations: 3

Publication: “Assessment of the anthelmintic activity and toxicity of metabolites of Dalea pogonathera (Fabaceae)”

Authors: Victoria McPherson, Haley Wolhart, Lindsay Engels, Gil N. Belofsky, Blaise Dondji

Journal: Phytochemistry Letters

Year: 2022

Citations: 1

 

 

 

 

Syed Luqman Ali | Drug Design | Best Researcher Award

Published on by Young Scientists Awards

Mr. Syed Luqman Ali | Drug Design | Best Researcher Award

Researcher, Abdul Wali Khan University Mardan KPK Pakistan, Pakistan

Mr. Syed Luqman Ali is an enthusiastic researcher specializing in bioinformatics, computational biology, vaccine design, cancer, and drug development. Currently pursuing an MPhil in Biochemistry at Abdul Wali Khan University Mardan (2025), he has published extensively on vaccine and drug design using advanced computational techniques like RNA-seq, molecular docking, and simulation. Mr. Ali is a skilled reviewer for several high-impact journals and a lecturer at Metanoia College of Nursing. With expertise in bioinformatics tools and programming languages, he is committed to advancing scientific knowledge in vaccine and drug research.

Publication Profile

Google scholar

Education

Mr. Syed Luqman Ali is currently pursuing his MPhil in Biochemistry at Abdul Wali Khan University Mardan, Pakistan, with an expected graduation in 2025. He completed his Bachelor’s degree in Biochemistry from the same institution in 2022, laying the foundation for his research career. Additionally, he holds a Diploma in Digital Information Technology from the Board of Technical Education Peshawar, Pakistan, earned in 2021. This diverse educational background has equipped him with a strong interdisciplinary skill set, combining biochemistry, digital technology, and computational biology for cutting-edge research.

Research Experience

Mr. Syed Luqman Ali has been an Experimental and Computational Researcher at Abdul Wali Khan University Mardan since 2019. His research focuses on vaccine and drug design, utilizing advanced computational techniques like RNA-seq analysis, molecular docking, and simulation. With extensive experience in leading bioinformatics databases such as KEGG, MetaCyc, and HADDOCK, Mr. Ali is proficient in tools like SnapGene, Cytoscape, and DAVID. His work contributes to the development of innovative vaccines and drug therapies, advancing scientific knowledge in bioinformatics and computational biology.

Technical Certifications

Mr. Syed Luqman Ali has acquired several technical certifications that complement his research expertise. He completed a Data Analysis with R program through Mindluster, enhancing his data analysis skills. Additionally, he has obtained certifications in Data Analysis with Python and Linux from Udemy, further strengthening his computational abilities. Mr. Ali also completed a Content Writing course through the DigiSkills Training Program from Virtual University, Lahore, improving his communication and writing skills for scientific documentation. These certifications underscore his commitment to continuous learning and professional development in bioinformatics and computational biology.

Awards and Achievements

Mr. Syed Luqman Ali has made significant contributions to the scientific community, with multiple publications in high-impact journals, showcasing his research prowess in bioinformatics and computational biology. His work has been recognized by peers and researchers worldwide. Additionally, Mr. Ali serves as a reviewer for several reputed scientific journals, contributing his expertise to the advancement of research. These achievements reflect his dedication to scientific excellence and his active role in shaping future advancements in his field. 📚🖋️🔬

Research Focus

Mr. Syed Luqman Ali’s research spans multiple bioinformatics and computational biology domains, particularly in vaccine and drug design, cancer immunology, and genomics. His work includes multi-epitope vaccine development using immunoinformatics and reverse vaccinology approaches, along with genomic annotation for vaccine target identification. He has contributed significantly to disease diagnostics and drug discovery, especially in areas like tuberculosis, SARS-CoV-2, Leishmania, and autoimmune disorders. His expertise also extends to advanced data analysis, molecular docking, and RNA-seq analysis, employing tools like KEGG, MetaCyc, and HADDOCK. 🧬💻💉

Publication Top Notes

  • Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
    Cited by: 20
    Year: 2023
  • Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica – a hierarchical subtractive proteomics and …
    Cited by: 15
    Year: 2023
  • Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome …
    Cited by: 12
    Year: 2023
  • Currently trending and futuristic biological modalities in the management of different types of diabetes: A comprehensive review
    Cited by: 9
    Year: 2023
  • Analysis of the capability of IgG antibodies and receptors with their relationships to food tolerance and autoimmune disorders
    Cited by: 6
    Year: 2023
  • Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs
    Cited by: 4
    Year: 2023
  • Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
    Cited by: 1
    Year: 2024
  • Genetic identification and determination of parasites (Babesia, Leptospira and Toxoplasma Gondi) in wild rats
    Cited by: 1
    Year: 2024
  • Placental histology for targeted risk assessment of recurrent spontaneous preterm birth
    Cited by: 1
    Year: 2024
  • Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
    Cited by: 1
    Year: 2024
  • Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
    Cited by: 1
    Year: 2024
  • Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches
    Cited by: 1
    Year: 2025
  • Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    Cited by: 1
    Year: 2024
  • A Comprehensive Methodological Review of Major Developments in Bioinformatics Pipelines for Transcriptomic Data Analysis
    Cited by: –
    Year: 2024
Conclusion

Mr. Ali’s solid academic background, innovative research contributions, advanced technical skills, and role as a mentor, he is undoubtedly a strong candidate for the Research for Best Researcher Award. His work in bioinformatics, drug design, vaccine development, and cancer research showcases his dedication to advancing scientific knowledge and making a global impact.